Congress Moves to Require Licenses for Exporting Digital Synthetic DNA/RNA Designs to Foreign Entities of Concern
Also known as: Biological Intellectual Property Protection Act of 2025
Legislative Progress
Key Points
Milestones
What Happens Next
Projected impacts based on AI analysis
Related News
4 articles
Cotton Introduces Bill to Protect American Biotech Innovation from Communist China
Announces the Biological Intellectual Property Protection Act of 2025 and describes a proposed Commerce licensing requirement for exports/transfers of designed synthetic DNA/RNA sequences to foreign entities of concern, with research/publication carve-outs.

Press Release: Cotton Introduces Legislation to Safeguard American Biotech Innovation from Chinese Theft
Roundup summarizing the bill’s stated purpose and core mechanism: a license requirement for exporting/transfer of synthetic DNA/RNA digital sequences to foreign entities of concern, plus exemptions tied to existing export rules.

New Bill: Representative Warren Davidson introduces H.R. 6624: Biological Intellectual Property Protection Act of 2025
Summarizes companion House legislation (H.R. 6624) creating a licensing requirement for exporting/transferring digital synthetic DNA/RNA sequences to foreign entities of concern, referencing exceptions under existing export regulations.